Madrid hosts the second congress of the first Spanish company that works to raise awareness of this discipline
The new minimally invasive methods for diagnosis and treatment of oral diseases dental visits will end up conquering Spanish. More and more professionals that are seeking a clinical practice based on noninvasive methods to meet the growing demand of patients seeking treatments that are not aggressive.
The minimally invasive approach encompasses all aspects of dentistry, promoting the practice of non-aggressive oral therapy. Starting from the premise that the most important thing is to preserve the original fabric, the concept embraces both the procedures for early diagnosis and treatment of disease, risks and associated symptoms, the latter prerequisite for final processing to produce a minimally invasive and therefore minimal trauma to the patient.
This new understanding of dentistry can be applied in the treatment of oral diseases such as caries, periodontal disease, occlusal wear, prosthodontic reconstruction, rehabilitation with implants, among many other procedures. Experts believe that we have a renewing vision of dentistry in which the patient has a high profile, while is committed to improving both their oral health dental and general health status.
What is minimally invasive dentistry?
discipline that promotes the maintenance of oral and dental health through diagnosis and aggressive treatment of minimal.
incorporates the latest technology to achieve the best clinical treatments.
anticipates demand for the patient, offering maximum effectiveness with minimal intervention.
adopting this philosophy of work, career progress is being made to the future.
Seomi, the first society of minimally invasive dentistry
In order to present minimally invasive dentistry, Seomi held the second congress of the first Spanish Society of Minimally Invasive Dentistry (Seomi), a non-profit organization that seeks to become a forum for the exchange and development of concepts own practice minimally invasive. To fulfill these purposes, Seomi performs the following activities:
sharing information and experiences
internal training and development of their members
Innovation in clinical skills
research projects
cooperation with other national and international companies working with the same objective
Its president, Dr. Carlos Aparicio, explains that "the real revolution of this century health through the increased level of responsibility of the individual in managing their own health. The minimally invasive guidance assumes that there are few things so precise and perfect as the human body to propose the conservation of the stomatognathic system in general, and the tooth with its supporting structures, in particular, both aesthetically and functionally.
All dental specialties continues Dr. Aparicio can use friendly processes: from prevention, arguably the most conservative treatment that we know, until surgery with implants. Any dentist, whatever their specialty should be interested in this working philosophy that seeks results of maximum efficiency with minimal intervention. In this regard, I am convinced that the practice of minimally invasive dentistry practice in Spanish consultations in the near future.
Seomi offers members the opportunity to access to exclusive services for innovation and quality in dentistry through meetings and publications of scientific, as well as the possibility of knowing the latest developments and case studies in the field of dentistry to www.seomi.org across the page. Furthermore, the Dental Associates have the opportunity to use the logo of the company in his office as a symbol of awareness for respect for the integrity of the patient.
Madrid hosts the second meeting of Seomi
The next few days 27 and 28 February, Seomi holds its second conference at the headquarters of the Meliá Avenida América with the aim of making known the benefits of this discipline and to encourage both general and specialist dentists adopt this philosophy of work daily clinical practice. This year the chairman of the meeting is Dr. Javier Alández.
Dr. Alández, says that with the title New Perspectives in Dentistry: The minimally invasive approach, the meeting in Madrid offers an attractive scientific program, with the presence of prominent international personalities in the field, most notably David Clark, founder of the Academy of Microscope Enhanced Dentistry, Marianella Sierraalta, Professor of Prosthodontics at the University of Michigan, Joao Caramés, professor at the Faculty of Dental Medicine, University of Lisbon; Shakibaie Behnam, MD of reference in Rheda-Wiedenbrueck / Germany in implantology and periodontics minimally invasive, and Giani Simon, Professor of Dentistry at the University of Insubria and University of Bologna. Next to them, are provided assistance from the national experts: Josune Antia, Radigales Manuel Antón, José María Aranguren, Patricia Gatón Andres Pascual, and Beatriz Rodriguez Vilaboa.
Thursday, October 29, 2009
Identified a region of chromosome 13 as a risk factor in Multiple Sclerosis.
It is published in the journal PLoS One:
This discovery is a breakthrough in understanding a disease that affects one in 1,000 people. The Research Institute of lHospital Universitari de la Vall dHebron presented as a benchmark in the latest scientific knowledge about the disease produced.
The research group in Neuroimmunology Clinical Research Institute of dHebron lHospital Barcelona Universitari Vall (IR-HUVH), led by Dr. Xavier Montalban, has participated in this study Multiple Sclerosis, a degenerative disease of origin unknown and no definitive cure. These results, published in the journal PloS One, acquire a top-level importance in the genetic knowledge of Multiple Sclerosis, and pointing to a new region on chromosome 13 as a risk factor for developing the disease. Moreover, not only contribute information to this effect, but the results also imply, most likely, a group of microRNAs located in this new region as key elements in the risk of developing the disease.
Multiple sclerosis is a neurodegenerative disease, chronic non-contagious and seriously affecting the mobility of the individual producing progressive disability. In fact, in Western countries, is the first most common cause of neurological disability. The symptoms appear when patients are between 20 and 40 years (most common neurological disease among young people, after epilepsy) and currently has no cure, although investigations have been started on drugs that could slow the process .
For this reason, the group of IR-HUVH Neuroimmunology focuses its research with the aim of improving the quality of life for patients with Multiple Sclerosis (MS) and deeper understanding of the pathogenic mechanisms of the disease, so develop new therapeutic treatments more effective. The success of this group lies in its direct involvement in the new advances in diagnosis, pathogenesis and therapy.
The study: a possible starting point for a new line of research
The IR-HUVH researchers conducted several previous steps until finally, they found two susceptibility genes of interest. First, they studied a group of 250 patients affected by Multiple Sclerosis (MS) and compared the results with control group of 250 healthy people in order to determine differences among some 500,000 polymorphisms within the genetic information. In particular, they studied what are called Snips-SNPs (Single Nucleotide Polimorphism) - or variants of the gene sequence for each individual, ie those most common variations, known and associated with our normal population. However, the polymorphisms studied 5000.000, and applying different criteria, differences were demonstrated between 384 SNPs.
Later, in a second step, these 384 genes were compared between 100 affected by MS and 100 healthy individuals. As a result of the comparison, there were Snips 8 genes that are expressed significantly in patients with sclerosis compared with healthy individuals.
Finally, a third step, no more validated SNPs 2 genes, one found in the HLA region (closely associated, by other studies, multiple sclerosis) and the other in another region that has not been associated with this disease before .
These results reinforce and give coherence to the study hypothesis, since, as already known for some time, there is a strong association between HLA genes and Multiple Sclerosis. The fact that one of the SNPs associated with disease is in the HLA region validates the methodology used in the study. Moreover, in recent decades, many researchers have attempted to identify new genes not associated with HLA but, so far, the results were not satisfactory enough. For this reason, researchers at the IR-HUVH offer thus an important step in identifying a new region located on chromosome 13q31.3 as a risk factor.
In this new area of concern identified include a group of microRNAs that may be responsible for risk of disease, explains Dr. Manel Comabella responsible for this study. These microRNAs are small molecules and proteins that do not translate that regulate the expression of other genes. MicroRNAs have been known for some time and its role in multiple sclerosis is unknown.
Similarly, another research group has found that the expression of some microRNAs in this region are different between patients with MS and individuals without the presence of the disease. This finding provides indirect evidence about the importance of this group of microRNAs, while reinforcing the importance of our findings, Dr. Comabella concrete. We are now studying how microRNAs influence this group and other genes that are very close to this region, the risk for this disease.
This discovery is a breakthrough in understanding a disease that affects one in 1,000 people. The Research Institute of lHospital Universitari de la Vall dHebron presented as a benchmark in the latest scientific knowledge about the disease produced.
The research group in Neuroimmunology Clinical Research Institute of dHebron lHospital Barcelona Universitari Vall (IR-HUVH), led by Dr. Xavier Montalban, has participated in this study Multiple Sclerosis, a degenerative disease of origin unknown and no definitive cure. These results, published in the journal PloS One, acquire a top-level importance in the genetic knowledge of Multiple Sclerosis, and pointing to a new region on chromosome 13 as a risk factor for developing the disease. Moreover, not only contribute information to this effect, but the results also imply, most likely, a group of microRNAs located in this new region as key elements in the risk of developing the disease.
Multiple sclerosis is a neurodegenerative disease, chronic non-contagious and seriously affecting the mobility of the individual producing progressive disability. In fact, in Western countries, is the first most common cause of neurological disability. The symptoms appear when patients are between 20 and 40 years (most common neurological disease among young people, after epilepsy) and currently has no cure, although investigations have been started on drugs that could slow the process .
For this reason, the group of IR-HUVH Neuroimmunology focuses its research with the aim of improving the quality of life for patients with Multiple Sclerosis (MS) and deeper understanding of the pathogenic mechanisms of the disease, so develop new therapeutic treatments more effective. The success of this group lies in its direct involvement in the new advances in diagnosis, pathogenesis and therapy.
The study: a possible starting point for a new line of research
The IR-HUVH researchers conducted several previous steps until finally, they found two susceptibility genes of interest. First, they studied a group of 250 patients affected by Multiple Sclerosis (MS) and compared the results with control group of 250 healthy people in order to determine differences among some 500,000 polymorphisms within the genetic information. In particular, they studied what are called Snips-SNPs (Single Nucleotide Polimorphism) - or variants of the gene sequence for each individual, ie those most common variations, known and associated with our normal population. However, the polymorphisms studied 5000.000, and applying different criteria, differences were demonstrated between 384 SNPs.
Later, in a second step, these 384 genes were compared between 100 affected by MS and 100 healthy individuals. As a result of the comparison, there were Snips 8 genes that are expressed significantly in patients with sclerosis compared with healthy individuals.
Finally, a third step, no more validated SNPs 2 genes, one found in the HLA region (closely associated, by other studies, multiple sclerosis) and the other in another region that has not been associated with this disease before .
These results reinforce and give coherence to the study hypothesis, since, as already known for some time, there is a strong association between HLA genes and Multiple Sclerosis. The fact that one of the SNPs associated with disease is in the HLA region validates the methodology used in the study. Moreover, in recent decades, many researchers have attempted to identify new genes not associated with HLA but, so far, the results were not satisfactory enough. For this reason, researchers at the IR-HUVH offer thus an important step in identifying a new region located on chromosome 13q31.3 as a risk factor.
In this new area of concern identified include a group of microRNAs that may be responsible for risk of disease, explains Dr. Manel Comabella responsible for this study. These microRNAs are small molecules and proteins that do not translate that regulate the expression of other genes. MicroRNAs have been known for some time and its role in multiple sclerosis is unknown.
Similarly, another research group has found that the expression of some microRNAs in this region are different between patients with MS and individuals without the presence of the disease. This finding provides indirect evidence about the importance of this group of microRNAs, while reinforcing the importance of our findings, Dr. Comabella concrete. We are now studying how microRNAs influence this group and other genes that are very close to this region, the risk for this disease.
New data confirm the remission of Crohn's disease
New data confirm the remission of Crohn's disease with the combined use of Remicade ® (infliximab) and azathioprine.
The results were made public during the Fourth Congress of the European Crohn's and Colitis Organization recently held in Hamburg Colitis
Around 69% of patients with Crohn's disease of moderate to severe and high levels of C reactive protein (CRP) and mucosal lesions go into remission with combination therapy of infliximab and azathioprine according to a subanalysis of the study SONIC
In Spain there are about 40,000 affected by Crohn's disease that first manifests itself in people between 15 and 30 years and are suffering from reduced quality of life
Results from a subanalysis of SONIC Phase III Study of Patients with Crohn's Disease, Naïve to Immunomodulators and Biologic Therapy among Patients suffering from these moderate to severe disease with high levels of C-reactive protein (CRP) have shown high rates of remission when treated with Remicade ® (infliximab), either alone or in combination with azathioprine. Specifically, 69% have achieved the goals of clinical disease remission and mucosal healing at week 26.
These figures confirm the main objectives set by the SONIC study that show how biological therapies that are based Remicade ® (infliximab) in combination therapy or monotherapy increased clinical remission of Crohn's disease and scarring of the mucosa after 26 weeks of treatment. 57% of all patients seen in the SONIC study who were treated with Remicade ® (infliximab) and azathioprine in combination achieved remission. This finding highlights on the 44% of patients reported treatment benefits only infliximab monotherapy and 31% of those who received only azathioprine.
Main results of the subgroup of patients analyzed
The results arising from this sub-analysis at 26 weeks of treatment SONIC study fall into three study groups:
Patients with elevated CRP levels and mucosal lesions (40% of patients observed):
or treatment with Remicade ® (infliximab) and azathioprine (69% remission), monotherapy with Remicade ® (infliximab) (57%), treatment with azathioprine (28%)
Patients who reported high levels of C-reactive protein (≥ 0.8 mg / dL), which account for 58%. In this case, the results recorded are:
or treatment with Remicade ® (infliximab) and azathioprine (64% remission), monotherapy with Remicade ® (infliximab) (48%), treatment with azathioprine (28%)
Patients with mucosal lesions (64% of patients observed in the study):
or treatment with Remicade ® (infliximab) and azathioprine (61% remission), monotherapy with Remicade ® (infliximab) (51%), treatment with azathioprine (30%)
According to Dr. Jean Frederic Colombel, Professor of Hepatogastroenterology Hospital Center of Lille, the results of the SONIC study have been very well received by gastroenterologists met in Hamburg, as they show some great benefits for patients and efficacy data and safety Remicade ® in the treatment of chronic inflammatory bowel disease remission by recording the inflammation and healing of mucosal lesions.
About SONIC
SONIC is a randomized clinical trial phase III, double-blind, designed to compare the efficacy and safety of Remicade ®, azathioprine monotherapy and combination therapy of both drugs in patients with Crohn's disease of moderate to severe and had not received treatments previously immunomodulators and biologic therapies. Of the total 508 patients who participated in the study, 170 were treated with azathioprine 2-2.5 mg / kg / day and placebo, 169 patients received REMICADE ® 5 mg / kg at weeks 0, 2, 6 and every 8 weeks then with placebo capsules and 169 patients received REMICADE ® 5 mg / kg and azathioprine 2 to 2.5 mg / kg for 30 weeks. 52% of patients were men with a mean age of 34 years with a mean disease duration of 2.3 years.
Crohn's Disease
Crohn's disease is a chronic inflammatory bowel disease that affects more than 400,000 people in Europe, over 40,000 of them registered in Spain. This disease is characterized by having a direct impact on quality of life for those affected because, besides suffering from hospitalization, surgery and loss of productivity, have episodes where they can get to having to urinate up to 25 times a day. It also gave the patient a disease that costs about as it is a chronic disease that, while not fatal, unpleasant symptoms that are a taboo subject among the general population.
Schering-Plow
Schering-Plow is a global pharmaceutical company dedicated to health care through scientific innovation. Through internal research and collaborations with partners, Schering-Plow researches, develops, manufactures and markets advanced drug therapies to help save lives and improve quality of life for many people around the world. For that the company applies its research and development of prescription and consumer products and animal health.
The mission of Schering-Plow and professional account with which everyone is "Winning the trust, day by day" of doctors, patients and customers. The Company is based in Kenilworth (New Jersey, USA). His website is http://www.schering-plough.com plough.es Spain.
The results were made public during the Fourth Congress of the European Crohn's and Colitis Organization recently held in Hamburg Colitis
Around 69% of patients with Crohn's disease of moderate to severe and high levels of C reactive protein (CRP) and mucosal lesions go into remission with combination therapy of infliximab and azathioprine according to a subanalysis of the study SONIC
In Spain there are about 40,000 affected by Crohn's disease that first manifests itself in people between 15 and 30 years and are suffering from reduced quality of life
Results from a subanalysis of SONIC Phase III Study of Patients with Crohn's Disease, Naïve to Immunomodulators and Biologic Therapy among Patients suffering from these moderate to severe disease with high levels of C-reactive protein (CRP) have shown high rates of remission when treated with Remicade ® (infliximab), either alone or in combination with azathioprine. Specifically, 69% have achieved the goals of clinical disease remission and mucosal healing at week 26.
These figures confirm the main objectives set by the SONIC study that show how biological therapies that are based Remicade ® (infliximab) in combination therapy or monotherapy increased clinical remission of Crohn's disease and scarring of the mucosa after 26 weeks of treatment. 57% of all patients seen in the SONIC study who were treated with Remicade ® (infliximab) and azathioprine in combination achieved remission. This finding highlights on the 44% of patients reported treatment benefits only infliximab monotherapy and 31% of those who received only azathioprine.
Main results of the subgroup of patients analyzed
The results arising from this sub-analysis at 26 weeks of treatment SONIC study fall into three study groups:
Patients with elevated CRP levels and mucosal lesions (40% of patients observed):
or treatment with Remicade ® (infliximab) and azathioprine (69% remission), monotherapy with Remicade ® (infliximab) (57%), treatment with azathioprine (28%)
Patients who reported high levels of C-reactive protein (≥ 0.8 mg / dL), which account for 58%. In this case, the results recorded are:
or treatment with Remicade ® (infliximab) and azathioprine (64% remission), monotherapy with Remicade ® (infliximab) (48%), treatment with azathioprine (28%)
Patients with mucosal lesions (64% of patients observed in the study):
or treatment with Remicade ® (infliximab) and azathioprine (61% remission), monotherapy with Remicade ® (infliximab) (51%), treatment with azathioprine (30%)
According to Dr. Jean Frederic Colombel, Professor of Hepatogastroenterology Hospital Center of Lille, the results of the SONIC study have been very well received by gastroenterologists met in Hamburg, as they show some great benefits for patients and efficacy data and safety Remicade ® in the treatment of chronic inflammatory bowel disease remission by recording the inflammation and healing of mucosal lesions.
About SONIC
SONIC is a randomized clinical trial phase III, double-blind, designed to compare the efficacy and safety of Remicade ®, azathioprine monotherapy and combination therapy of both drugs in patients with Crohn's disease of moderate to severe and had not received treatments previously immunomodulators and biologic therapies. Of the total 508 patients who participated in the study, 170 were treated with azathioprine 2-2.5 mg / kg / day and placebo, 169 patients received REMICADE ® 5 mg / kg at weeks 0, 2, 6 and every 8 weeks then with placebo capsules and 169 patients received REMICADE ® 5 mg / kg and azathioprine 2 to 2.5 mg / kg for 30 weeks. 52% of patients were men with a mean age of 34 years with a mean disease duration of 2.3 years.
Crohn's Disease
Crohn's disease is a chronic inflammatory bowel disease that affects more than 400,000 people in Europe, over 40,000 of them registered in Spain. This disease is characterized by having a direct impact on quality of life for those affected because, besides suffering from hospitalization, surgery and loss of productivity, have episodes where they can get to having to urinate up to 25 times a day. It also gave the patient a disease that costs about as it is a chronic disease that, while not fatal, unpleasant symptoms that are a taboo subject among the general population.
Schering-Plow
Schering-Plow is a global pharmaceutical company dedicated to health care through scientific innovation. Through internal research and collaborations with partners, Schering-Plow researches, develops, manufactures and markets advanced drug therapies to help save lives and improve quality of life for many people around the world. For that the company applies its research and development of prescription and consumer products and animal health.
The mission of Schering-Plow and professional account with which everyone is "Winning the trust, day by day" of doctors, patients and customers. The Company is based in Kenilworth (New Jersey, USA). His website is http://www.schering-plough.com plough.es Spain.
Monday, August 24, 2009
Uterine Uru - million
Description
Uterus occurring in some harmful, some are harmless mass. Timely treatment is done, 10-15 kg. can grow up.
This disorder is more common between 30-40 years of age, after menopause is not very common. Ur even formed an existing, smaller when you begin to enter menopause. Uterine cervix cancer is not treated on time ur can translate.
Reason
1 - unbalanced and insufficient nutrition.
2 - the body of harmful substances in food or drink. (Alcohol, coffee, cigarettes, bacon and sausage, etc.)
3 - nervous system disorders.
4 - Sexual dissatisfaction.
5 - celibacy a long time.
6 - not to childbearing.
Symptoms
Following the occurrence of ur uterus itself with the following symptoms indicate.
1 - Regl prolongation of the duration of bleeding and bleeding more replication.
2 - between the two menstrual bleeding seen in days.
3 - between the pressure and weight perception in Makadla oud.
4 - Pelvic and abdominal pain.
5 - swelling in the legs.
6 - constipation.
7 - urinating frequently, often and be in dribs and drabs.
Treatment Modality
The sooner treatment is started in ur uterus so the easier the treatment. And a few of the above symptoms are seen, not seen by a doctor immediately as ur and not be detected. If you have ur;
1 - something disrupts the body's health should be abandoned.
2 - poisoning the body food and drink items must be abandoned.
3 - body and soul will tire things should be avoided.
4 - Rotten teeth, tonsils, appendix if there should be treated.
5 - to reduce the bleeding to stop bleeding herbs should be used.
6 - Drink plenty of raw vegetables and fruit should continue to eat.
Uterus occurring in some harmful, some are harmless mass. Timely treatment is done, 10-15 kg. can grow up.
This disorder is more common between 30-40 years of age, after menopause is not very common. Ur even formed an existing, smaller when you begin to enter menopause. Uterine cervix cancer is not treated on time ur can translate.
Reason
1 - unbalanced and insufficient nutrition.
2 - the body of harmful substances in food or drink. (Alcohol, coffee, cigarettes, bacon and sausage, etc.)
3 - nervous system disorders.
4 - Sexual dissatisfaction.
5 - celibacy a long time.
6 - not to childbearing.
Symptoms
Following the occurrence of ur uterus itself with the following symptoms indicate.
1 - Regl prolongation of the duration of bleeding and bleeding more replication.
2 - between the two menstrual bleeding seen in days.
3 - between the pressure and weight perception in Makadla oud.
4 - Pelvic and abdominal pain.
5 - swelling in the legs.
6 - constipation.
7 - urinating frequently, often and be in dribs and drabs.
Treatment Modality
The sooner treatment is started in ur uterus so the easier the treatment. And a few of the above symptoms are seen, not seen by a doctor immediately as ur and not be detected. If you have ur;
1 - something disrupts the body's health should be abandoned.
2 - poisoning the body food and drink items must be abandoned.
3 - body and soul will tire things should be avoided.
4 - Rotten teeth, tonsils, appendix if there should be treated.
5 - to reduce the bleeding to stop bleeding herbs should be used.
6 - Drink plenty of raw vegetables and fruit should continue to eat.
Period Irregularities
Short periods of time women must take into account the luteal phase failure (riding the short period of the second period) can be a cause of infertility.
Normally, 28 days, one should see a woman, 14 days later (day of ovulation) 28 days before completing menstruate again if faced with luteal phase insufficiency status means.
Luteal phase (periyoyodun second period); menstrual cycle after ovulation in the other one is the elapsed time until the start. Copies of the second period of frequent short drive, but easy to treat a difficult situation is recognized. The tissue inside the uterus of laying in the right place at the right time is not already. Baby's uterus settlement, decorated the interior of the uterus tissue was very interested in the timing of spawning time for pregnancy to occur after a period of brevity and continuity may affect continuing.
An ideal menstrual cycle before the beginning of the body a few days before menstruation FSH (follicle stimulating hormone) secretion starts. This is a result of carrying the egg begins to grow cysts called follicles. Follicle after reaching sufficient maturity LH (Luteinizing Hormone) secretion starts. With these hormones in the egg follicle tubes to crack and are discarded. More intense with a liquid again after cracking follicle dollars. Consisting of the second half of the menstrual cycle structure called the corpus luteum from secreting the hormone progesterone is responsible for. Increased progesterone levels, decorated the interior of the uterus and vascular tissue healing to be by increasing the thick of the uterus is tailored to hold the embryo. Progesterone also prevents the early onset of menstruation. In a normal menstrual cycle averages 12 days for the corpus luteum secretes progesterone.
Luteal Phase Insufficiency? Nde normal menstrual cycle may be broken in several ways. Poor follicle development, corpus luteumun early termination, decorated the interior of the uterus that does not respond, tap the appropriate progesterona between luteal phase may cause failure.
Luteal phase progesterone is responsible for the increase in body temperature. Body temperature to follow patients for a period of 12 days of body temperature does not remain high farketmektedirler. Also in the next menstrual period after menstruation is 12-14 days before ovulation is noticeable.
Luteal phase progesterone level of failure are suspected blood from seven to 7 days after ovulation is checked. Progesterone levels are low, usually from outside the treatment is in the form of progesterone supplements to give. However, the lack of follicular development can lead to low progesterone levels. Pieces in the middle with ultrasound to measure follicle size also needs to look at the blood hormone levels. If the normal follicular development, luteal phase support is given porogesteron. If insufficient follicle development, ovary stimulating drugs may need to give. In this way, and better quality eggs is provided to follicle development may occur.
The tests for diagnosis;
Usually, the diagnosis of blood progesterone levels, luteal phase length and can be sufficient, while longer follow-up ultrasound in patients with endometrial biopsy may be required.
Normally, the next piece of endometrial biopsiyi is necessary to take a few days ago. In addition, this patient's menstrual period not pregnant are also required to be identified.
During this process a small amount of tissue in the uterus is taken for pathological examination. Tissue was examined at the level for the information obtained is very important. Patalog, quantity and texture of that day whether it is appropriate to examine the development. If appropriate, the internal tissues of the uterus is determined to be compatible with the cycle. If non-compliance if more than two day, tissues are not compatible.
Luteal phase insufficiency is a common diagnosis in case it is very easy. Also, the answer is the right treatment immediately. Therefore, the most important point in this process, the real reason is to determine the appropriate treatment plan.
Normally, 28 days, one should see a woman, 14 days later (day of ovulation) 28 days before completing menstruate again if faced with luteal phase insufficiency status means.
Luteal phase (periyoyodun second period); menstrual cycle after ovulation in the other one is the elapsed time until the start. Copies of the second period of frequent short drive, but easy to treat a difficult situation is recognized. The tissue inside the uterus of laying in the right place at the right time is not already. Baby's uterus settlement, decorated the interior of the uterus tissue was very interested in the timing of spawning time for pregnancy to occur after a period of brevity and continuity may affect continuing.
An ideal menstrual cycle before the beginning of the body a few days before menstruation FSH (follicle stimulating hormone) secretion starts. This is a result of carrying the egg begins to grow cysts called follicles. Follicle after reaching sufficient maturity LH (Luteinizing Hormone) secretion starts. With these hormones in the egg follicle tubes to crack and are discarded. More intense with a liquid again after cracking follicle dollars. Consisting of the second half of the menstrual cycle structure called the corpus luteum from secreting the hormone progesterone is responsible for. Increased progesterone levels, decorated the interior of the uterus and vascular tissue healing to be by increasing the thick of the uterus is tailored to hold the embryo. Progesterone also prevents the early onset of menstruation. In a normal menstrual cycle averages 12 days for the corpus luteum secretes progesterone.
Luteal Phase Insufficiency? Nde normal menstrual cycle may be broken in several ways. Poor follicle development, corpus luteumun early termination, decorated the interior of the uterus that does not respond, tap the appropriate progesterona between luteal phase may cause failure.
Luteal phase progesterone is responsible for the increase in body temperature. Body temperature to follow patients for a period of 12 days of body temperature does not remain high farketmektedirler. Also in the next menstrual period after menstruation is 12-14 days before ovulation is noticeable.
Luteal phase progesterone level of failure are suspected blood from seven to 7 days after ovulation is checked. Progesterone levels are low, usually from outside the treatment is in the form of progesterone supplements to give. However, the lack of follicular development can lead to low progesterone levels. Pieces in the middle with ultrasound to measure follicle size also needs to look at the blood hormone levels. If the normal follicular development, luteal phase support is given porogesteron. If insufficient follicle development, ovary stimulating drugs may need to give. In this way, and better quality eggs is provided to follicle development may occur.
The tests for diagnosis;
Usually, the diagnosis of blood progesterone levels, luteal phase length and can be sufficient, while longer follow-up ultrasound in patients with endometrial biopsy may be required.
Normally, the next piece of endometrial biopsiyi is necessary to take a few days ago. In addition, this patient's menstrual period not pregnant are also required to be identified.
During this process a small amount of tissue in the uterus is taken for pathological examination. Tissue was examined at the level for the information obtained is very important. Patalog, quantity and texture of that day whether it is appropriate to examine the development. If appropriate, the internal tissues of the uterus is determined to be compatible with the cycle. If non-compliance if more than two day, tissues are not compatible.
Luteal phase insufficiency is a common diagnosis in case it is very easy. Also, the answer is the right treatment immediately. Therefore, the most important point in this process, the real reason is to determine the appropriate treatment plan.
Chocolate Cyst
Womb (uterus) is located within each month of pregnancy will host the pregnancy is not prepared and when deprived of adequate hormonal support because units (menstruation) in bleeding poured layer of special cells "endometrium" is called. This layer of cells in the body is located just inside the uterus. Of these cells in the body of the uterus take place in an area other than "endometriosis" is called disease. This situation is most common in the ovaries, uterus back in space (Douglas cavity), vagina and intestinal last section between the intestinal tract on the surface of the tube over or around, the bonds holding womb and bladder or abdomen on the membrane surfaces, in surgical wounds, stitched during birth, the precise angle, very rare as the navel, nose can be seen in distant organs such as the membrane. The most common place with 75% ovaries are.
Inner layer of the uterus in the course of the menstrual cycle each month and becomes thicker as a result of a period of time a tissue is taken out of the body bleeding. Outside surface of inner layer of the uterine cervix is placed in a location with a thickening of the menstrual cycle occurs again and again is an effort to remove these tissues with blood. Endometriosis disease where the tissues of the vagina opening to the outside environment, in contrast to the uterus are closed system and bleeding it off into my site (usually in the abdominal cavity or ovarian tissue is into is that in later periods where otherwise known as endometrioma, chocolate cyst, called ovarian cysts causes.) Happens. This internal bleeding which can cause adhesions in the inner regions and the related symptoms occur. This amount is very small amount of internal bleeding is not life-threatening move.
Who is most common in?
Endometriosis as a disease of women in reproductive age are accepted. Without complaint and with no other reason a woman can be identified that are evaluated. 3% of all women-in 5 children have difficulty being detected in 40% of the couples. In one of the first degree relatives of endometriosis in a woman pegged at risk of disease is about 7 times more. Endometriosis is very rare and very late in the menopausal women in the patient is examined. Even been reported in the literature can be seen in men.
Why occurs?
What factors cause is not known exactly where. Explain why the various theories put forward are aimed at. Most accepted view that two genetic predisposition as the women, the abdomen in the specific surfaces or tissue cells undergo structural changes and uterine inner layer is to act as the other the inner layer of the uterus (endometrium) of the fallopian tubes into the abdomen occurs in migrating to this theory that retrograde mesturasyon The theory is called. (The theory is to become more possible and reasonable.)
Specify how to give?
One of the most frequently encountered in patients with endometriosis complain is that it is extremely painful. An increasing order of pain severity is monitored. Focus on the cause of pain in endometriosis secreted by the effect of certain substances called prostaglandin uterine contractions occurring in. However, with the severity of the pain is no relationship between the degree of disease. A mild endometriosis may cause violence, such as severe pain in patients with endometriosis in an ultra-light pieces can be seen even in severe pain may not be any pain. However, earlier onset of labor and the progress continues for more than may indicate stages of the disease. The pain typically begins a few days before one and to the highest level reached with bleeding and bleeding continues throughout. In fact, sometimes this pain may not respond to drugs painkillers. Chronic groin pain than labor units in the endometriosis and low back pain may be. This pain may spread legs towards the.
Endometriosis, can cause pain during sexual intercourse. This situation in most of endometriosis patients with bleeding disorders are common to. However, in the form of premenstrual bleeding common brown staining is typical for endometriosis.
Most of endometriosis patients because of inability to have children can apply for PhD. In general, the complaints of infertility in 10-20% of women have endometriosis at different levels. The relationship between endometriosis and infertility could be is not fully understood. Especially in mild to moderate whether endometriozisin cause infertility is controversial. However, the most commonly accepted theory in space endometriozisin pelvic inflammation caused by some kind of lead to the release of certain substances and materials and have a negative effect on follicle and egg development is that. Peritoneum of these substances secreted in the egg and sperm even, tubal function, and even the fertilized egg is implanted endometriuma been proposed may be of some impact on. Another is just a matter of mild endometriosis does not cause infertility. This is the main cause of infertility in patients with poor sperm quality, such as ovulation disorders or other pathology known unexplained infertility (sterility) as well as in cases of unknown causes are. Only to the table accompanying endometriosis is an additional pathology.
On the other hand a known cause of severe endometriosis is infertility. The resulting adhesions and anatomical reproductive system disorders disrupt the normal function of the fertilization cause problems. Even without adhesions, chocolate cysts by disturbing the normal ovulation can lead to infertility.
Why chocolate cyst: Accumulated blood remains red to brown color as time passed, and black indicates the correct change. Ovarian tissue of blood accumulated in this former Endometrioma are built from and within view of the cyst is reminiscent of the liquid chocolate.
Complaints and findings may appear with endometriosis
- Chronic pelvic pain
- Copies of being painful (dysmenorrhea)
- Infertility
- Ectopic pregnancy
- Painful sexual intercourse (disparonia)
- Low back pain
- Back pain
- Leg pain
- Nausea and vomiting
- Abdominal pain
- Constipation or diarrhea
- Anus pain hit
- Bloody stool
- Makadi bleeding
- Towards the coccyx pain
- Blood in urine
- Burning urination
- Side pain
- Frequently urination
- Copies or bleeding nose bleeding simultaneously in various parts of the body of bleeding and bruising.
How is it diagnosed?
Be seen as poles of the lesions diagnosed Endometriozisin and pathological examination are placed with. So surgery is essential for definitive diagnosis. In the sense of history in patients suspected endometriosis also have infertility problems should be absolutely diagnostic laparoscopy. Peritoneum during laparoscopy, the uterus, Douglas space, inner tubes, such as formation of pelvic endometriosis observing small investigated the presence of focal adhesions is monitored while in severe cases.
The most important diagnostic ultrasonography in the diagnosis of endometriosis at the beginning of the income test. Ultrasonography in the diagnosis of ovarian cysts, but the chocolate had settled, while useful for pelvic endometriosis is insufficient to provide information. Deep in the ovaries can be overlooked, but this had settled endometriomalar laparoscopic ultrasonographic examination with a careful masses can be easily noticed.
Ultrasound examination of the cases heard in the blood endometriomalardan doubt called Ca-125 as a result of a marker at diagnosis is important for support. Originating from the ovaries secreted in some cancers these tumor markers are also increased in the presence of endometriosis, but the blood level does not rise as in malignant diseases.
Phases
Endometriosis disease, where the region, propagation, depth and size are according to the stage. Minimal disease stage 1, stage 2 light, mid-stage 3 and stage 4 represents the severe endometriosis. Created with the stage of disease that has no direct connection between the complaints.
How is it treated?
There is no definitive treatment Endometriozisin permanent. The aim of treatment for the pain and infertility is to eliminate. Medical and surgical treatments can be applied for this purpose. Medical treatment is based on the principle endometriozisin are estrogen-dependent disease. Pregnancy and menopause, endometriosis is preventing the formation of two natural conditions. Hormonal therapy is to mimic the natural state of these two objectives. In both cases the effect of estrogen on the endometrium will disappear in the wrong location had settled in the suppression of endometrial tissue are expected.
Hormonal status during pregnancy to mimic observed when using birth control pills, in order to mimic menepozu called danazol or GnRH analogue drugs are used. Lasting 3-6 months in the treatment of blood estrogen level as in the low levels in natural menopause is. Usually applied once a month in the form of injection of GnRH analogue treatment is very expensive form of treatment. Long-term use of GnRH anaolgları osteoporosis, after menopause such as hot flushes may be seen near the lead to be supplied with medicines that contain estrogen. Called add-back therapy may seem to contrast this to stop. However, the purpose of blood estrogen levels cause endometriosis baskılayacak low and not osteoporosis is to keep a high enough range.
The studies for the pain of endometriosis is applied in medical treatment to be effective, but a positive effect on infertility is not shown. Therefore, in patients admitted with a medical reason for infertility treatment is not recommended.
Should be preferred in patients with severe endometriosis is surgical treatment approaches. Developments in laparoscopic surgical techniques, especially for these patients treated in an effective way allows. For example, chocolate cysts extracted 50% of patients treated within 6 months without having to remain pregnant. Anatomical level of the re-provision and eliminating pain and is extremely important in increasing reproductive potential.
Assisted reproductive techniques:
Treated after surgery because of infertility a woman becomes pregnant within 6 months in self-assisted reproductive techniques are not the next option. If the tubes are open vaccination may be tried. Vaccination in cases where the last alternative in vitro fertilization failed application. This group of patients, especially the large chocolate cyst was removed a reduction in ovarian reserve can be expected. In addition, for some reason unknown, this decrease can be seen in the rate of fertilization in endometriosis patients.
Inner layer of the uterus in the course of the menstrual cycle each month and becomes thicker as a result of a period of time a tissue is taken out of the body bleeding. Outside surface of inner layer of the uterine cervix is placed in a location with a thickening of the menstrual cycle occurs again and again is an effort to remove these tissues with blood. Endometriosis disease where the tissues of the vagina opening to the outside environment, in contrast to the uterus are closed system and bleeding it off into my site (usually in the abdominal cavity or ovarian tissue is into is that in later periods where otherwise known as endometrioma, chocolate cyst, called ovarian cysts causes.) Happens. This internal bleeding which can cause adhesions in the inner regions and the related symptoms occur. This amount is very small amount of internal bleeding is not life-threatening move.
Who is most common in?
Endometriosis as a disease of women in reproductive age are accepted. Without complaint and with no other reason a woman can be identified that are evaluated. 3% of all women-in 5 children have difficulty being detected in 40% of the couples. In one of the first degree relatives of endometriosis in a woman pegged at risk of disease is about 7 times more. Endometriosis is very rare and very late in the menopausal women in the patient is examined. Even been reported in the literature can be seen in men.
Why occurs?
What factors cause is not known exactly where. Explain why the various theories put forward are aimed at. Most accepted view that two genetic predisposition as the women, the abdomen in the specific surfaces or tissue cells undergo structural changes and uterine inner layer is to act as the other the inner layer of the uterus (endometrium) of the fallopian tubes into the abdomen occurs in migrating to this theory that retrograde mesturasyon The theory is called. (The theory is to become more possible and reasonable.)
Specify how to give?
One of the most frequently encountered in patients with endometriosis complain is that it is extremely painful. An increasing order of pain severity is monitored. Focus on the cause of pain in endometriosis secreted by the effect of certain substances called prostaglandin uterine contractions occurring in. However, with the severity of the pain is no relationship between the degree of disease. A mild endometriosis may cause violence, such as severe pain in patients with endometriosis in an ultra-light pieces can be seen even in severe pain may not be any pain. However, earlier onset of labor and the progress continues for more than may indicate stages of the disease. The pain typically begins a few days before one and to the highest level reached with bleeding and bleeding continues throughout. In fact, sometimes this pain may not respond to drugs painkillers. Chronic groin pain than labor units in the endometriosis and low back pain may be. This pain may spread legs towards the.
Endometriosis, can cause pain during sexual intercourse. This situation in most of endometriosis patients with bleeding disorders are common to. However, in the form of premenstrual bleeding common brown staining is typical for endometriosis.
Most of endometriosis patients because of inability to have children can apply for PhD. In general, the complaints of infertility in 10-20% of women have endometriosis at different levels. The relationship between endometriosis and infertility could be is not fully understood. Especially in mild to moderate whether endometriozisin cause infertility is controversial. However, the most commonly accepted theory in space endometriozisin pelvic inflammation caused by some kind of lead to the release of certain substances and materials and have a negative effect on follicle and egg development is that. Peritoneum of these substances secreted in the egg and sperm even, tubal function, and even the fertilized egg is implanted endometriuma been proposed may be of some impact on. Another is just a matter of mild endometriosis does not cause infertility. This is the main cause of infertility in patients with poor sperm quality, such as ovulation disorders or other pathology known unexplained infertility (sterility) as well as in cases of unknown causes are. Only to the table accompanying endometriosis is an additional pathology.
On the other hand a known cause of severe endometriosis is infertility. The resulting adhesions and anatomical reproductive system disorders disrupt the normal function of the fertilization cause problems. Even without adhesions, chocolate cysts by disturbing the normal ovulation can lead to infertility.
Why chocolate cyst: Accumulated blood remains red to brown color as time passed, and black indicates the correct change. Ovarian tissue of blood accumulated in this former Endometrioma are built from and within view of the cyst is reminiscent of the liquid chocolate.
Complaints and findings may appear with endometriosis
- Chronic pelvic pain
- Copies of being painful (dysmenorrhea)
- Infertility
- Ectopic pregnancy
- Painful sexual intercourse (disparonia)
- Low back pain
- Back pain
- Leg pain
- Nausea and vomiting
- Abdominal pain
- Constipation or diarrhea
- Anus pain hit
- Bloody stool
- Makadi bleeding
- Towards the coccyx pain
- Blood in urine
- Burning urination
- Side pain
- Frequently urination
- Copies or bleeding nose bleeding simultaneously in various parts of the body of bleeding and bruising.
How is it diagnosed?
Be seen as poles of the lesions diagnosed Endometriozisin and pathological examination are placed with. So surgery is essential for definitive diagnosis. In the sense of history in patients suspected endometriosis also have infertility problems should be absolutely diagnostic laparoscopy. Peritoneum during laparoscopy, the uterus, Douglas space, inner tubes, such as formation of pelvic endometriosis observing small investigated the presence of focal adhesions is monitored while in severe cases.
The most important diagnostic ultrasonography in the diagnosis of endometriosis at the beginning of the income test. Ultrasonography in the diagnosis of ovarian cysts, but the chocolate had settled, while useful for pelvic endometriosis is insufficient to provide information. Deep in the ovaries can be overlooked, but this had settled endometriomalar laparoscopic ultrasonographic examination with a careful masses can be easily noticed.
Ultrasound examination of the cases heard in the blood endometriomalardan doubt called Ca-125 as a result of a marker at diagnosis is important for support. Originating from the ovaries secreted in some cancers these tumor markers are also increased in the presence of endometriosis, but the blood level does not rise as in malignant diseases.
Phases
Endometriosis disease, where the region, propagation, depth and size are according to the stage. Minimal disease stage 1, stage 2 light, mid-stage 3 and stage 4 represents the severe endometriosis. Created with the stage of disease that has no direct connection between the complaints.
How is it treated?
There is no definitive treatment Endometriozisin permanent. The aim of treatment for the pain and infertility is to eliminate. Medical and surgical treatments can be applied for this purpose. Medical treatment is based on the principle endometriozisin are estrogen-dependent disease. Pregnancy and menopause, endometriosis is preventing the formation of two natural conditions. Hormonal therapy is to mimic the natural state of these two objectives. In both cases the effect of estrogen on the endometrium will disappear in the wrong location had settled in the suppression of endometrial tissue are expected.
Hormonal status during pregnancy to mimic observed when using birth control pills, in order to mimic menepozu called danazol or GnRH analogue drugs are used. Lasting 3-6 months in the treatment of blood estrogen level as in the low levels in natural menopause is. Usually applied once a month in the form of injection of GnRH analogue treatment is very expensive form of treatment. Long-term use of GnRH anaolgları osteoporosis, after menopause such as hot flushes may be seen near the lead to be supplied with medicines that contain estrogen. Called add-back therapy may seem to contrast this to stop. However, the purpose of blood estrogen levels cause endometriosis baskılayacak low and not osteoporosis is to keep a high enough range.
The studies for the pain of endometriosis is applied in medical treatment to be effective, but a positive effect on infertility is not shown. Therefore, in patients admitted with a medical reason for infertility treatment is not recommended.
Should be preferred in patients with severe endometriosis is surgical treatment approaches. Developments in laparoscopic surgical techniques, especially for these patients treated in an effective way allows. For example, chocolate cysts extracted 50% of patients treated within 6 months without having to remain pregnant. Anatomical level of the re-provision and eliminating pain and is extremely important in increasing reproductive potential.
Assisted reproductive techniques:
Treated after surgery because of infertility a woman becomes pregnant within 6 months in self-assisted reproductive techniques are not the next option. If the tubes are open vaccination may be tried. Vaccination in cases where the last alternative in vitro fertilization failed application. This group of patients, especially the large chocolate cyst was removed a reduction in ovarian reserve can be expected. In addition, for some reason unknown, this decrease can be seen in the rate of fertilization in endometriosis patients.
Itching of the vagina
Complaints
Or excessive itching in the vagina, different color and rotten smelling discharge in question.
Causes
Fungal infections: Dark, white, peynirimsi have a discharge, irritation and itching in the vagina in question. Fungal infection, often after taking antibiotics or birth control pills or during pregnancy develops.
Buffer or forgetting of the diaphragm: you have a busy stream, but no other symptoms. Check if you have forgotten, and forgotten tampon or diaphragm.
Inflammation of the pelvis / salpenjit: Colorless, rotten smelling vaginal discharge and / or pelvis may be sore.
Low fever and tremor, fatigue, back in the bottom of the pain, irregular bleeding and loss of appetite may also occur. Salpenjit pelvis and inflammation (inflammation of the fallopian tubes) requires immediate medical attention.
What you can do yourself?
Unless your doctor recommends otherwise, do not have a shower.
If there is itching vagina, and avoid scratching the area twice a day with plain water rinse. Wear cotton panties and corset or stay away from tight pants.
To sleep without wearing panties.
Prevention
Of safe sex and male partners to wear latex condoms protect against sexually transmitted diseases helps.
If you are prone to fungal infections, using antibiotics, prescription drug use cork.
Live active cultured yogurt dishes will be useful.
Other sexually transmitted diseases Diabetes Causes Allergies Menopause
Treatment of the Girl in your child's routine is not something buluğdan ago vaginal discharge. In this case may have been sexually assaulted.
We talk with the doctor. To comfort your child, you can: Area twice a day, gently rinse with plain water. The only wear cotton panties. With additive-free and fragrance-free detergents for laundry wash. Teach your gold to clean it.
Or excessive itching in the vagina, different color and rotten smelling discharge in question.
Causes
Fungal infections: Dark, white, peynirimsi have a discharge, irritation and itching in the vagina in question. Fungal infection, often after taking antibiotics or birth control pills or during pregnancy develops.
Buffer or forgetting of the diaphragm: you have a busy stream, but no other symptoms. Check if you have forgotten, and forgotten tampon or diaphragm.
Inflammation of the pelvis / salpenjit: Colorless, rotten smelling vaginal discharge and / or pelvis may be sore.
Low fever and tremor, fatigue, back in the bottom of the pain, irregular bleeding and loss of appetite may also occur. Salpenjit pelvis and inflammation (inflammation of the fallopian tubes) requires immediate medical attention.
What you can do yourself?
Unless your doctor recommends otherwise, do not have a shower.
If there is itching vagina, and avoid scratching the area twice a day with plain water rinse. Wear cotton panties and corset or stay away from tight pants.
To sleep without wearing panties.
Prevention
Of safe sex and male partners to wear latex condoms protect against sexually transmitted diseases helps.
If you are prone to fungal infections, using antibiotics, prescription drug use cork.
Live active cultured yogurt dishes will be useful.
Other sexually transmitted diseases Diabetes Causes Allergies Menopause
Treatment of the Girl in your child's routine is not something buluğdan ago vaginal discharge. In this case may have been sexually assaulted.
We talk with the doctor. To comfort your child, you can: Area twice a day, gently rinse with plain water. The only wear cotton panties. With additive-free and fragrance-free detergents for laundry wash. Teach your gold to clean it.
Subscribe to:
Posts (Atom)
